Vanguard Capital Management’s Edesa Biotech EDSA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$345K Hold
81,839
– – ﹤0.01% 3733
2026
Q2
$665K Sell
81,839
-4,127
-5% -$37.2K ﹤0.01% 3669
2026
Q1
$450K Buy
+85,966
New +$258K ﹤0.01% 3694

Other funds holding EDSA

Vanguard Capital Management's EDSA Position: Q3 2026 in Review

Vanguard Capital Management held its Edesa Biotech (EDSA) position steady in Q3 2026 at 81,839 shares worth $345K. The position accounts for ﹤0.01% of the portfolio, ranked #3733.

Vanguard Capital Management first reported a position in EDSA in Q1 2026 and has held it in 3 quarters since. The position peaked at $665K in Q2 2026. 34 funds tracked by Wall St. Rank hold EDSA as of Q3 2026.

  • Vanguard Capital Management held 81,839 shares of Edesa Biotech worth $345K as of Q3 2026.
  • Vanguard Capital Management left its Edesa Biotech share count unchanged in Q3 2026.
  • Edesa Biotech made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #3733 holding.
  • Vanguard Capital Management first reported a position in Edesa Biotech in Q1 2026 and has held it in 3 quarters since.
  • Vanguard Capital Management's Edesa Biotech position peaked at $665K in Q2 2026.
  • 34 funds tracked by Wall St. Rank held Edesa Biotech as of Q3 2026.

Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.